Priority 5 from the Womb Cancer PSP
| UNCERTAINTY: Are blood tests, including markers like CA125, useful in predicting duration of survivorship and/or recurrent disease? (JLA PSP Priority 5) | |
|---|---|
| Overall ranking | 5 |
| JLA question ID | 0042/5 |
| Explanatory note | Not available for this PSP |
| Evidence | A summary of the evidence checked (.PDF) for this PSP |
| Health Research Classification System category | Cancer |
| PSP information | |
|---|---|
| PSP unique ID | 0042 |
| PSP name | Womb Cancer |
| Total number of uncertainties identified by this PSP. | 209 (see a full list of all questions checked against existing evidence (.PDF)) |
| Date of priority setting workshop | 3 December 2015 |